PHENTERMINE HYDROCHLORIDE

Product NDC: 61919-186
11-digit product format: 619190186
Labeler code: 61919
Product ID: 61919-186_b1a71882-78f9-297e-e053-2a95a90a760e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: PHENTERMINE HYDROCHLORIDE
Dosage form: TABLET
Route: ORAL
Labeler: Direct_Rx
Application: ANDA040555
Marketing category: ANDA
Marketing start: 2020-10-14
Marketing end: 0000-00-00
Substance: PHENTERMINE HYDROCHLORIDE
Active strength: 38 mg/1
Pharmacologic classes: Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	61919-186		I	Inactivated by FDA	2026-08-07
excluded product	product	61919-186		I	Inactivated by FDA	2026-08-07
excluded package	package	61919-186	61919-186-30	I	Inactivated by FDA	2026-08-07
excluded package	package	61919-186	61919-186-07	I	Inactivated by FDA	2026-08-07
excluded package	package	61919-186	61919-186-14	I	Inactivated by FDA	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 59 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-186-14	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-186-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-186-07	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-186-14	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-186-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-186-07	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-186-14	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-186-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-186-07	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-186-14	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-186-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-186-07	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-186-14	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-186-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-186-07	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-186-14	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-186-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-186-07	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-186-14	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-186-07	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-186-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-186-14	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-186-07	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-186-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-186-14	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-186-07	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-186-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61919-186-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61919-186-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61919-186-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61919-186-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61919-186-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61919-186-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61919-186-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040555-001	PHENTERMINE HYDROCHLORIDE	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL			2005-04-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040555-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040555-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040555-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040555-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040555-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040555-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040555-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040555-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040555-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040555-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040555-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040555-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040555-001	AA	1	`ea99ee380514…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040555-001	AA	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3d272a3f-17c0-421d-bc43-3cbdb719258d	Product name	1	20250303
32c2b0bd-1f13-4890-99e0-dcd2ea16e1ab	Product name	2	20230717
ebeae3eb-385d-62da-8827-5ffa80b14e90	Product name	2	20170810
1d682039-1122-1cb7-f3f4-c0a028b98748	Product name	4	20170124
8ef9ca65-1a6c-7225-351d-36066d0f8e56	Product name	3	20161229

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-186-07	2025-01-30	C162847	48780-1	2cef2736-6c6e-d83d-e063-dadaa90ab31f	PHENTERMINE HCL C-IV
61919-186-14	2025-01-30	C162847	48780-1	2cef2736-6c6e-d83d-e063-dadaa90ab31f	PHENTERMINE HCL C-IV
61919-186-30	2024-01-30	C162847	48780-1	1030e365-44b1-111a-e063-dadaa90a10e2	PHENTERMINE HYDROCHLORIDE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
61919-186-30	PHENTERMINE HYDROCHLORIDE	30 in 1 BOTTLE	TABLET	30	8
61919-186-07	PHENTERMINE HYDROCHLORIDE	7 in 1 BOTTLE	TABLET	7	6
61919-186-14	PHENTERMINE HYDROCHLORIDE	14 in 1 BOTTLE	TABLET	14	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-186-30	EA - Each	61919-186	fb97e723-3c78-4aaf-b8ad-d1410a8bc0a4	1	2014-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-186	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	8	Legacy NDC, 1 package rows	20200122_501437ae-f4a2-4e54-b033-eccc53a06037.zip
61919-186	PHENTERMINE HCL C-IV CAPSULE PHENTERMINE HYDROCHLORIDE TABLET [DIRECT_RX]	6	Legacy NDC, 2 package rows	20230413_8a947cf6-c578-0405-e053-2995a90a3e0e.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0K2I505OTV	PHENTERMINE HYDROCHLORIDE	1197-21-3	PHENTERMINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	501437ae-f4a2-4e54-b033-eccc53a06037	8
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	501437ae-f4a2-4e54-b033-eccc53a06037	8
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	501437ae-f4a2-4e54-b033-eccc53a06037	8
900038	phentermine HCl 30 MG Oral Capsule	PSN	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	8a947cf6-c578-0405-e053-2995a90a3e0e	6
900038	phentermine hydrochloride 30 MG Oral Capsule	SCD	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	8a947cf6-c578-0405-e053-2995a90a3e0e	6
900038	phentermine hydrochloride 30 MG (equivalent to phentermine 24 MG) Oral Capsule	SY	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	8a947cf6-c578-0405-e053-2995a90a3e0e	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61919-186-07	61919018607	7 TABLET in 1 BOTTLE (61919-186-07)	7 tablet	2020-10-14	0000-00-00	No	No	Current
61919-186-14	61919018614	14 TABLET in 1 BOTTLE (61919-186-14)	14 tablet	2020-10-14	0000-00-00	No	No	Current
61919-186-30	61919018630	30 TABLET in 1 BOTTLE (61919-186-30)	30 tablet	2014-01-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
PHENTERMINE HCL C-IV	Direct_Rx	2023-04-12	HUMAN PRESCRIPTION DRUG LABEL	6
PHENTERMINE HYDROCHLORIDE	DIRECT RX	2020-01-21	HUMAN PRESCRIPTION DRUG LABEL	8